Postpartum Depression Clinical Trial
Official title:
Interaction Between Genetic Factors and Maternal Stressors During Pregnancy in the Risk of Postpartum Depression
"The prevalence of postpartum depression (PPD) is approximately 13%. PPD is associated with a higher maternal morbidity and mortality, and also with pervasive effects on the emotional, cognitive and behavioral development of the infant. Stressful life events, socio-demographic and obstetrical risk factors have been associated with the risk of PPD. Genetics risk factors of PPD have also been identified. We are presently studying for the first time how maternal stressors may interact with genetic factors to increase the risk of PPD (Gene x Environment interaction)".
"The prevalence of postpartum depression (PPD) is approximately 13%. PPD is associated with a higher maternal morbidity and mortality, and also with pervasive effects on the emotional, cognitive and behavioral development of the infant. Stressful life events, socio-demographic and obstetrical risk factors have been associated with the risk of PPD. Genetics risk factors of PPD have also been identified. We are presently studying for the first time how maternal stressors may interact with genetic factors to increase the risk of PPD (Gene x Environment interaction). We want first to analyze the allelic association between SNPs of 5-HT, HPA and neurodevelopment genes and PPD with a case control association study We then analyse the interaction between maternal stressors during pregnancy and SNPS of our candidate genes (CRHR1, 5-HTT, TPH, BDNF, HMCN1). 3000 Caucasian mothers are included after pregnancy in 8 maternities and are evaluated at the inclusion, at 8 weeks and at 1 year with DIGS, FISC, EPDS and HAD, Stressful life events (Paykel). Blood are collected for all subjects for DNA extraction. At week 8 and 1 year after pregnancy we search PPD with EDPS and DSM-IV criteria of depression". ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06348316 -
Early Half Swaddling and Kangaroo Care Practices on Maternal Sleep Quality and Postpartum Depression in Term Babies
|
N/A | |
Completed |
NCT05322161 -
Yoga in the NICU for Parents Study
|
N/A | |
Withdrawn |
NCT03709004 -
Pacifiers and Breastfeeding Among Mothers at Risk for Postpartum Depression
|
N/A | |
Completed |
NCT06305325 -
Coparenting Intervention to Prevent Postpartum Depression
|
N/A | |
Not yet recruiting |
NCT05055674 -
The Effects of Motherly on Postpartum Depression
|
N/A | |
Enrolling by invitation |
NCT02323152 -
PREVENTION OF POSTPARTUM DEPRESSION DEVELOPMENT IN WOMEN WITH VERY HIGH RISK
|
N/A | |
Not yet recruiting |
NCT01658098 -
Prevalence of Postpartum Depression in Hospital Jose E. Gonzalez
|
N/A | |
Completed |
NCT00961402 -
The Effect of Exercise on Preventing PostPartum Depression
|
Phase 2 | |
Completed |
NCT01312883 -
Mothers Avoiding Depression Through Empowerment Intervention Trial
|
N/A | |
Completed |
NCT00360204 -
Improving Health Outcomes for New Mothers and Babies
|
Phase 3 | |
Unknown status |
NCT00548743 -
Translating Research Into Practice for Postpartum Depression
|
N/A | |
Completed |
NCT04146025 -
Nurtured in Nature
|
N/A | |
Not yet recruiting |
NCT06442774 -
MamaConecta: Digital Tool for Maternal Mental Health
|
N/A | |
Recruiting |
NCT05137925 -
Mindful Moms: Mechanisms of Mindfulness-based Cognitive Therapy During Pregnancy and Postpartum
|
N/A | |
Not yet recruiting |
NCT05299398 -
Prevention of Postpartum Depression: A Pilot Placebo-controlled Trial of Trazodone
|
Phase 1 | |
Completed |
NCT04925765 -
Virtual Reality Biofeedback for Postpartum Anxiety and Depression
|
N/A | |
Recruiting |
NCT06053515 -
Rosie the Chatbot: Leveraging Automated and Personalized Health Information Communication
|
N/A | |
Completed |
NCT04037085 -
Ketamine to Improve Recovery After Cesarean Delivery - Part 1
|
Phase 2 | |
Completed |
NCT05059600 -
A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting
|
Phase 4 | |
Completed |
NCT06136520 -
The Effect of Baby Massage Training Given to Pregnant Women on Maternal Attachment and Postpartum Depression
|
N/A |